Supplementation with carnosine decreases plasma triglycerides and modulates atherosclerotic plaque composition in diabetic apo E−/− mice-Reference-Cited by-同舟云学术

Supplementation with carnosine decreases plasma triglycerides and modulates atherosclerotic plaque composition in diabetic apo E−/− mice

Published:2014-02 Issue:2 Volume:232 Page:403-409
ISSN:0021-9150
Container-title:Atherosclerosis
language:en
Short-container-title:Atherosclerosis

Author:

Brown Bronwyn E.^ORCID,Kim Christine H.J.,Torpy Fraser R.,Bursill Christina A.,McRobb Lucinda S.,Heather Alison K.,Davies Michael J.,van Reyk David M.

Publisher

Elsevier BV

Subject

Cardiology and Cardiovascular Medicine

Reference30 articles.

1. Is there evidence that oral hypoglycemic agents reduce cardiovascular morbidity/mortality? Yes;Bianchi;Diabetes Care,2009

2. Recipes for creating animal models of diabetic cardiovascular disease;Hsueh;Circ Res,2007

3. The role of AGEs in cardiovascular disease;Jandeleit-Dahm;Curr Pharm Des,2008

4. Physiology and pathophysiology of carnosine;Boldyrev;Physiol Rev,2013

5. Carnosine and its possible roles in nutrition and health;Hipkiss;Adv Food Nutr Res,2009

Cited by 55 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. State of the Art in the Development of Human Serum Carnosinase Inhibitors;Molecules;2024-05-24

2. Histidine-containing dipeptide supplementation improves delayed recall: a systematic review and meta-analysis;Nutrition Reviews;2023-11-27

3. Carnosine Did Not Affect Vascular and Metabolic Outcomes in Patients with Prediabetes and Type 2 Diabetes: A 14-Week Randomized Controlled Trial;Nutrients;2023-11-19

4. Nutraceutical and Nanonutraceutical in the Management of CVD and Hypertension;Handbook of Nutraceuticals;2023-10-27

5. A Green and Cost-Effective Chromatographic Method for the Measurement of the Activity of Human Serum Carnosinase;Separations;2023-08-21